에 대한 최신 뉴스 Shelf Drilling (OTC:SHLLF) 주식

Shelf Drilling Ltd operates as a shallow-water offshore drilling contractor. The company is engaged in the drilling and completion of exploratory and developmental offshore oil and natural gas wells. The business operates in a single segment Contract services. Geographically, it derives a majority of its revenue from Saudi Arabia and also has a presence in Thailand; Nigeria; India, and Other Countries.

SHELF DRILLING LTD by Shelf Drilling Ltd.

Shelf Drilling Ltd

Barclays analyst Julian Mitchell maintains Dover (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOV#NYSE">DOV</a>) with a Equal-Weight and lowers the price target from $205 to $180.

News

Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Dover, Lowers Price Target to $180

RBC Capital analyst Greg Pardy reiterates Vermilion Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/VET#TSX">VET</a>) with a Sector Perform and maintains C$16 price target.

Reiteration

TSX:VET

RBC Capital Reiterates Sector Perform on Vermilion Energy, Maintains C$16 Price Target

Macro Economic Events

WIIM

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are lower, giving back some gains after surging on Wednesday following President Trump's 90-day tariff pause.

Barclays analyst David Anderson maintains Chart Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GTLS#NYSE">GTLS</a>) with a Equal-Weight and lowers the price target from $165 to $160.

GTLS

Barclays Maintains Equal-Weight on Chart Industries, Lowers Price Target to $160

Stifel analyst Mark Astrachan maintains Freshpet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) with a Buy and lowers the price target from $135 to $115.

FRPT

Stifel Maintains Buy on Freshpet, Lowers Price Target to $115

Barclays analyst Luke Sergott maintains Charles River (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) with a Equal-Weight and lowers the price target from $160 to $145.

Barclays Maintains Equal-Weight on Charles River, Lowers Price Target to $145

<a href="https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/">https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/</a>&nbsp;

Politics

General

Kansas City Fed's Schmid Says Growing Possibility The Fed Will Have To Balance Inflation Risks Against Growth And Employment; Says Intend To Remain Focused On Inflation, Do Not Take Much Solace From Theory That Tariffs May Have Only Temporary Effect On Inflation; Says He Is Concerned Further Increase Could Push Up Inflation Expectations, Given Previous High Inflation; Says  Not Willing To Take Any Chances With Fed's Credibility On Inflation; Says Growing Supply Of U.S. Treasury Debt Along With Potentially

RBC Capital analyst Drew McReynolds reiterates Corus Entertainment (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CJR#TSX">CJR</a>) with a Sector Perform and maintains C$0.2 price target.

TSX:CJR

TSX:CJR/B

RBC Capital Reiterates Sector Perform on Corus Entertainment, Maintains C$0.2 Price Target

Movers

Trading Ideas

AREB

American Rebel Holdings Shares Halted On Circuit Breaker

Stifel analyst Jim Duffy maintains Fox Factory Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOXF#NASDAQ">FOXF</a>) with a Buy and lowers the price target from $40 to $34.

FOXF

Stifel Maintains Buy on Fox Factory Holding, Lowers Price Target to $34

Barclays analyst Luke Sergott maintains Certara (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERT#NASDAQ">CERT</a>) with a Equal-Weight and lowers the price target from $13 to $11.

CERT

Barclays Maintains Equal-Weight on Certara, Lowers Price Target to $11

Barclays analyst Adrienne Yih maintains Capri Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>) with a Equal-Weight and lowers the price target from $19 to $13.

CPRI

Barclays Maintains Equal-Weight on Capri Holdings, Lowers Price Target to $13

Barclays analyst Luke Sergott maintains Bruker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRKR#NASDAQ">BRKR</a>) with a Overweight and lowers the price target from $60 to $50.

BRKR

Barclays Maintains Overweight on Bruker, Lowers Price Target to $50

Stifel analyst J. Bruce Chan maintains Forward Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FWRD#NASDAQ">FWRD</a>) with a Hold and lowers the price target from $29 to $22.

FWRD

Stifel Maintains Hold on Forward Air, Lowers Price Target to $22

<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="683" src="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08140846/johannes-plenio-fmTde1Fe23A-unsplash-1024x683.jpg" alt="" class="wp-image-10044" srcset="https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08140846/johannes-plenio-fmTde1Fe23A-unsplash-1024x683.jpg 1024w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08140846/johannes-plenio-fmTde1Fe23A-unsplash-300x200.jpg 300w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08140846/johannes-plenio-fmTde1Fe23A-unsplash-768x512.jpg 768w,https://contributor-assets.benzinga.com/wp-content/uploads/2025/04/08140846/johannes-plenio-fmTde1Fe23A-unsplash.jpg 1200w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
In early 2025, inflation was back in the headlines. New tariffs have driven up the cost of imports, and businesses are once again recalibrating their forecasts. But while headlines linger on price pressure and policy shifts, smart investors have already turned their gaze forward. They&#8217;re not ignoring inflation but navigating it strategically, with eyes firmly fixed on innovation.
At the end of the day, the question isn&#8217;t just, &#8220;How do we hedge?&#8221; It&#8217;s &#8220;what comes next?&#8221;
<h3 class="wp-block-heading">Smart Money in 2025: Focused on the Future</h3>
While traditional markets react to short-term volatility, smart capital is moving with intention—toward industries and technologies that offer long-term growth and structural relevance. Here&#8217;s where that money is flowing now:
<h4 class="wp-block-heading">1. AI and Automation</h4>
Artificial intelligence has moved from buzzword to baseline. In 2025, it's woven into industries from manufacturing to medicine. Investors are backing everything from AI chips and cloud infrastructure to vertical AI solutions designed for legal, healthcare, and logistics sectors.
These investments aren't just about potential—they're about productivity. AI is helping businesses cut costs, optimize workflows, and weather macroeconomic shifts like inflation more efficiently.
<h4 class="wp-block-heading">2. Blockchain Infrastructure and Tokenized Assets</h4>
While crypto hype has cooled, blockchain is quietly becoming a serious foundation for future finance. Asset tokenization is allowing for fractional ownership of real estate, art, and private equity—and institutional investors are paying attention.
Smart money is targeting the technology layer: custody platforms, compliance solutions, and cross-border payment networks that operate faster and cheaper than legacy systems.
<h4 class="wp-block-heading">3. Climate Tech and Energy Innovation</h4>
Energy remains a major inflation driver, especially with tariffs affecting global supply chains. As a result, capital is flowing toward technologies that promise greater energy independence and cost efficiency: battery tech, green hydrogen, carbon capture, and smart grid infrastructure.
Climate tech is no longer a niche ESG play—it&#8217;s a strategic asset class.
<h4 class="wp-block-heading">4. Digital Infrastructure</h4>
With remote operations now fully embedded in business models, companies are investing in stronger digital backbones. This includes data centers, cybersecurity, edge computing, and AI-enhanced logistics.
The key insight: no matter what the economy is doing, businesses can't afford digital downtime. And investors know it.
<h4 class="wp-block-heading">5. Emerging Market Innovation</h4>
From Southeast Asia to Africa, local startups are scaling faster than ever. Mobile-first fintech, agri-tech, and clean energy solutions are leapfrogging old models. As U.S. and European markets mature, emerging economies are drawing a new wave of innovation-seeking capital.
These aren't just value plays—they're growth engines.
<h3 class="wp-block-heading">Why Innovation Is the Real Hedge</h3>
The most forward-thinking investors in 2025 understand that innovation isn't just exciting—it's strategic. In a world where inflation may flare unpredictably, the best defense isn't always gold or government bonds. It's backing the technologies that can grow, adapt, and even thrive in times of disruption.
<h3 class="wp-block-heading">Final Thought: Inflation May Shape the Headlines, But Innovation Is Shaping the Future</h3>
Recent tariffs and macro shifts have reawakened inflation concerns. But the savviest capital isn't retreating—it's reallocating. It's moving toward long-term plays that go beyond short-term noise.
From inflation to innovation isn't just a catchy transition—it's a mindset. In 2025, that mindset will shape the portfolios that will define the next decade.

Equities

Long Ideas

Opinion

From Inflation To Innovation: Where The Smart Money Is Moving In 2025

Barclays analyst Luke Sergott maintains Avantor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) with a Overweight and lowers the price target from $23 to $18.

AVTR

Barclays Maintains Overweight on Avantor, Lowers Price Target to $18

RBC Capital analyst Steven Shemesh maintains Walmart (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) with a Outperform and lowers the price target from $107 to $102.

RBC Capital Maintains Outperform on Walmart, Lowers Price Target to $102

<a href="https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/" title="https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/">https://www.kansascityfed.org/speeches/remarks-on-the-economic-outlook/</a>

Global

Kansas City Fed's Schmid Says Tariff Announcements Have Elevated Economic Uncertainty, Coincided With Falling Sentiment And Rise In Short-term Inflation Expectations; Says Prepared Remarks Do Not Address March Cpi Or President Donald Trump's Announced Pause On Some Tariffs; Says Relative To Earlier In The Year, There Is A Marked Increase In Risk Of Higher Inflation, Lower Employment And Growth; Says Growing Possibility The Fed Will Have To Balance Inflation Risks Against Growth And Employment

U.S. stocks were lower, with the Dow Jones index dipping over 800 points on Thursday.
Shares of PriceSmart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSMT#NASDAQ">PSMT</a>) rose sharply during Thursday's session following better-than-expected <a href="https://www.benzinga.com/quote/PSMT">second-quarter earnings.</a>
Pricesmart reported quarterly earnings of $1.45 per share which beat the analyst consensus estimate of $1.40 per share. The company reported quarterly sales of $1.363 compared to the analyst consensus estimate of $1.359 billion.
PriceSmart shares jumped 7.2% to $91.93 on Thursday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Keros Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KROS#NASDAQ">KROS</a>) shares jumped 17.7% to $12.16. The company announced that its board has initiated a formal review process to evaluate strategic alternatives to maximize shareholder value.</li>
<li>GDS Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GDS#NASDAQ">GDS</a>) gained 10% to $21.40.</li>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) rose 9% to $19.84.</li>
<li>USA Rare Earth, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USAR#NASDAQ">USAR</a>) jumped 8.6% to $8.00.</li>
<li>Enact Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACT#NASDAQ">ACT</a>) gained 8% to $36.04 after the company announced it is set to join the S&amp;P SmallCap 600 on April 16.</li>
<li>SBC Medical Group Holdings Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBC#NASDAQ">SBC</a>) rose 6.6% to $3.3800.</li>
<li>DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) rose 6.7% to $71.33 after the company received FDA clearance for its G7 15-day continuous glucose monitoring system.</li>
<li>ATRenew Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) gained 5% to $2.3350.</li>
<li>Gold Fields Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>) shares rose 4.6% to $22.54.</li>
<li>Harmony Gold Mining Company Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HMY#NYSE">HMY</a>) gained 4.4% to $15.32.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44730791/top-3-health-care-stocks-that-could-lead-to-your-biggest-gains-in-q2">Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In Q2</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

DXCM

KROS

PSMT

RERE

SMMT

USAR

PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday

Barclays analyst Luke Sergott maintains Agilent Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/A#NYSE">A</a>) with a Equal-Weight and lowers the price target from $138 to $115.

Comments

Shelf Drilling

뉴스

에 대한 최신 뉴스 Shelf Drilling (OTC:SHLLF) 주식

뉴스

파트너 / 기고자

벤징가 글로벌